Abstract
This year, the world market in 2005 for In Vitro Diagnostics will be in excess of $20bn - but what will it be next year, or in 2009? visiongains brand new management report has the answers. The largest market is for Molecular Diagnostics, but will it continue to grow? The US currently dominates the market, whilst Germany has the largest market in Europe, but is also the third in the world.
Visiongains senior-level report tackles these topics, in-depth:
- Regulation
- Molecular Technologies
- Nucleic Acid Testing
- Protein Chip Technologies
- In Vitro Diagnostics at Point of Care Use
- Personal use of In Vitro Diagnostics
- Future Use of In Vitro Diagnostics in Diabetes
- Future Use of In Vitro Diagnostics in Cancer
- In Vitro Diagnostics in Cardiac Monitoring
- Genetic Testing
- Future Markets
- Future Growth Areas
This report is packed with industry data, brought together from primary and secondary sources. With company analysis, country breakdowns, government findings, and visiongain analysis, this annual report is regarded as the leading in its field. The rapid growth of molecular diagnostics has increased as the proliferation of information concerning the human genome have paved the way for commercial diagnostic protocols based on developing technologies. You need to remain aware of changes and developments in this market and only one report can do this for you. visiongains report is only available now and only by ordering it today can you stay fully informed and up-to-date. I look forward to receiving your order, today.
View Cart
